Implementation of the Hybrid Treatment in Clinical Care. A SCED. (hybrid-sced)

Örebro University, Sweden

Status: Active, not recruiting

Conditions: Emotional Problem; Chronic Pain

Treatments: Behavioral: Hybrid treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT05082922

HYBRID2.0

Details and patient eligibility

About

In society today, mental health problems, specifically stress-, anxiety- and depressive disorders, are a primary cause of long-term sick leave, leading to significant societal costs and suffering. One important issue hindering implementation of successful treatments is that there is a marked co-occurrence between these problems and somatic health problems, such as different types of pain. An important key to solving this problem is to develop a more integrated conceptualization of, and treatment model for, these patients' health problems. Specifically, one way to understand the co-occurrence between mental and somatic health problems is offered by the 'transdiagnostic' perspective. The aim of this project is to implement and evaluate the effectiveness of a transdiagnostic emotion-focused treatment protocol in clinical context. The treatment addresses comorbid mental (stress, anxiety- and depressive) and somatic health (pain) problems and targets core emotion regulation processes that are hypothesized to maintain and exacerbate these problems.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• > 11 points on the anxiety or depression subscale, Hospital Anxiety and Depression scale
• somatic health problems (pain > 3 months) with functional impairment (>3 on question 2 of the Multidimensional Pain Inventory, MPI, OR > 20 points on question 21-24 of the Örebro Musculoskeletal Pain Questionnaire, ÖMPQ)

Exclusion criteria

• severe psychiatric problems requiring immediate other treatment
• current psychological treatment
• recently started psychopharmacological treatment for anxiety or depression (<3 months prior to planned treatment)
• insufficient mastery of the Swedish language

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Single Blind

---

50 participants in 2 patient groups

No treatment waiting period

No Intervention group

Description:

Participants are randomized to a 4, 5, or 6 week waiting period. Weekly measurements are collected throughout this period.

Hybrid treatment

Experimental group

Description:

Hybrid treatment. Weekly measurements are collected throughout treatment.

Treatment:

Behavioral: Hybrid treatment